Vanda Pharmaceuticals Inc. (VNDA): Price and Financial Metrics

VNDA POWR Grades

• VNDA scores best on the Value dimension, with a Value rank ahead of 99.89% of US stocks.
• VNDA's strongest trending metric is Sentiment; it's been moving up over the last 177 days.
• VNDA's current lowest rank is in the Growth metric (where it is better than 17.17% of US stocks).

VNDA Stock Summary

• With a price/earnings ratio of 68.25, VANDA PHARMACEUTICALS INC P/E ratio is greater than that of about 91.45% of stocks in our set with positive earnings.
• For VNDA, its debt to operating expenses ratio is greater than that reported by merely 9.44% of US equities we're observing.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.2 for VANDA PHARMACEUTICALS INC; that's greater than it is for only 13.42% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to VANDA PHARMACEUTICALS INC are ACLS, SCKT, MDRX, JKHY, and VIAV.
• VNDA's SEC filings can be seen here. And to visit VANDA PHARMACEUTICALS INC's official web site, go to www.vandapharma.com.

VNDA Valuation Summary

• In comparison to the median Healthcare stock, VNDA's price/sales ratio is 66.67% lower, now standing at 1.7.
• Over the past 205 months, VNDA's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for VNDA.

VNDA Growth Metrics

The year over year cash and equivalents growth rate now stands at -7.22%.
• Its 5 year net cashflow from operations growth rate is now at 513.47%.
• Its 2 year net income to common stockholders growth rate is now at -84.51%.

VNDA's revenue has moved up $73,566,000 over the prior 49 months.

The table below shows VNDA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	257.919	49.175	6.492
2022-06-30	262.696	45.735	10.993
2022-03-31	266.205	59.067	18.072
2021-12-31	268.682	64.214	33.152
2021-09-30	268.316	56.909	34.264
2021-06-30	258.529	56.886	32.44

VNDA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VNDA has a Quality Grade of B, ranking ahead of 90.12% of graded US stocks.
• VNDA's asset turnover comes in at 0.483 -- ranking 88th of 682 Pharmaceutical Products stocks.
• NEOG, CLVS, and AMRN are the stocks whose asset turnover ratios are most correlated with VNDA.

The table below shows VNDA's key quality metrics over time.